Gene Regulatory Mechanisms that Repress BMP2 in Pathological Calcification

病理钙化中抑制 BMP2 的基因调控机制

基本信息

  • 批准号:
    9216823
  • 负责人:
  • 金额:
    $ 39.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-15 至 2020-07-31
  • 项目状态:
    已结题

项目摘要

The goal of this project is to understand how aging and chronic kidney disease (CKD) promote bone morphogenetic protein 2 (BMP2) synthesis that furthers pathological calcification of the heart valves and vasculature. Post-transcriptional regulatory mechanisms repress BMP2 in aorta and aortic valve. We hypothesize that (1) this repression is essential for controlling BMP2 levels in the adult and that (2) conditions such as aging and CKD impair the function of factors that mediate this repression in healthy heart valves and aorta. We will test these hypotheses in aged normal mice (24 months) and in the Klotho null mouse which models age-related disorders, including CKD. Klotho null mice suffer premature aging and death occurs at 7 - 8 weeks of age. At this time, extensive calcification of the heart valves, vasculature, and other soft tissues has occurred. AIM 1 is to test the influence of conditionally deleting a strong repressive element in the 3'untranslated region (UTR) of Bmp2 on calcification in normal aged mice and in Klotho null mice with premature aging and aging associated renal dysfunction. We will use recently developed Bmp2 alleles to assess how the deletion of this potent post-transcriptional repressor influences the course of calcification associated with aging and renal dysfunction. Preliminary results indicate that the UCS inhibits calcification. AIM 2 is to identify and compare miRNA signatures unique to young, healthy aorta and aortic valve to the signatures of these tissues from normal aged mice and in Klotho null mice with premature aging and severe vascular calcification. Within these profiles, we will focus on post- transcriptional repressive factors (miRNAs) that target the Bmp2 UCS and contribute to 3'UTR mediated repression in healthy tissues. AIM 3 is to test how selected and validated miRNAs influence the expression Bmp2 and downstream osteogenic events that lead to calcification in Klotho null mice bearing our unique transgenes. Our novel Bmp2 reporter mouse will expedite pre-clinical testing of miRNA therapies that prevent pathological calcification. Our newly developed Bmp2 allele (Aim 1) will differentiate changes due these miRNAs targeting Bmp2 relative to off-target genes. The outcomes of the proposed research will be (1) increased understanding of how BMP2 influences pathological calcification, (2) the identification and analyses of potential miRNA biomarkers, and (3) new therapeutic leads for controlling pathological calcification.
该项目的目的是了解衰老和慢性肾脏疾病(CKD)如何促进 骨形态发生蛋白2(BMP2)合成,促进了病理钙化 心脏瓣膜和脉管系统。 转录后调节机制抑制主动脉和主动脉瓣中的BMP2。我们 假设(1)这种抑制对于控制成年人的BMP2水平至关重要 (2)衰老和CKD等条件损害了调解这一点的因素的功能 在健康的心脏瓣膜和主动脉中抑制。 我们将在老年正常小鼠(24个月)和klotho null小鼠中检验这些假设 哪些模型与年龄有关的疾病,包括CKD。 klotho null小鼠过早衰老 死亡发生在7-8周龄。目前,心脏瓣膜广泛钙化, 脉管系统和其他软组织发生了。 目的1是测试有条件删除强烈压制元素的影响 BMP2在正常老年小鼠和klotho null中的钙化中的3'ununtranslated区域(UTR) 过早衰老和衰老相关的肾功能障碍的小鼠。我们最近将使用 开发的BMP2等位基因,以评估该有效的转录后阻遏物的删除 影响与衰老和肾功能障碍相关的钙化过程。初步的 结果表明,UCS抑制钙化。 AIM 2是识别和比较年轻,健康主动脉和主动脉独特的miRNA签名 瓣膜到正常老年小鼠和klotho null小鼠的阀 过早衰老和严重的血管钙化。在这些配置文件中,我们将专注于职位 针对BMP2 UCS并有助于3'UTR的转录抑制因子(miRNA) 健康组织中介导的抑制作用。 AIM 3是测试选择和验证的miRNA如何影响BMP2的表达和 下游的成骨事件导致klotho null小鼠的钙化,带有我们独特的 转基因。我们的新型BMP2报告基因鼠标将加快miRNA的临床前测试 预防病理钙化的疗法。我们新开发的BMP2等位基因(AIM 1)将 由于这些靶向BMP2相对于靶向基因的miRNA而区分变化。 拟议研究的结果将是(1)对BMP2的了解增加 影响病理钙化,(2)潜在miRNA的识别和分析 生物标志物和(3)新的治疗铅用于控制病理钙化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

MELISSA B ROGERS的其他基金

Gene Regulatory Mechanisms that Repress BMP2 in Pathological Calcification
病理钙化中抑制 BMP2 的基因调控机制
  • 批准号:
    9922580
    9922580
  • 财政年份:
    2017
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
Regulation of BMP2 in CKD Induced Calcification in the Klotho Aging Model
BMP2 在 Klotho 老化模型中 CKD 诱导钙化中的调节
  • 批准号:
    9349635
    9349635
  • 财政年份:
    2016
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID REGULATED GENES AND EMBRYOS
视黄酸调节基因和胚胎
  • 批准号:
    6351389
    6351389
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID--REGULATED GENES AND EARLY EMBRYOS
视黄酸——调控基因和早期胚胎
  • 批准号:
    2203458
    2203458
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID: REGULATED GENES AND EARLY EMBRYOS
视黄酸:调控基因和早期胚胎
  • 批准号:
    2403348
    2403348
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID--REGULATED GENES AND EARLY EMBRYOS
视黄酸——调控基因和早期胚胎
  • 批准号:
    2203457
    2203457
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID: REGULATED GENES AND EARLY EMBRYOS
视黄酸:调控基因和早期胚胎
  • 批准号:
    2673736
    2673736
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID REGULATED GENES AND EMBRYOS
视黄酸调节基因和胚胎
  • 批准号:
    6682949
    6682949
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID REGULATED GENES AND EMBRYOS
视黄酸调节基因和胚胎
  • 批准号:
    6044989
    6044989
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
RETINOIC ACID: REGULATED GENES AND EARLY EMBRYOS
视黄酸:调控基因和早期胚胎
  • 批准号:
    2641598
    2641598
  • 财政年份:
    1994
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别:
Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
  • 批准号:
    10736171
    10736171
  • 财政年份:
    2023
  • 资助金额:
    $ 39.73万
    $ 39.73万
  • 项目类别: